Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Oct 23:9:48.
doi: 10.1186/1471-2393-9-48.

Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania)

Affiliations
Randomized Controlled Trial

Treatment of retained placenta with misoprostol: a randomised controlled trial in a low-resource setting (Tanzania)

Heleen J van Beekhuizen et al. BMC Pregnancy Childbirth. .

Abstract

Background: Retained placenta is one of the common causes of maternal mortality in developing countries where access to appropriate obstetrical care is limited. Current treatment of retained placenta is manual removal of the placenta under anaesthesia, which can only take place in larger health care facilities. Medical treatment of retained placenta with prostaglandins E1 (misoprostol) could be cost-effective and easy-to-use and could be a life-saving option in many low-resource settings. The aim of this study is to assess the efficacy and safety of sublingually administered misoprostol in women with retained placenta in a low resource setting.

Design: Multicentered randomised, double-blind, placebo-controlled trial, to be conducted in 5 hospitals in Tanzania, Africa.

Inclusion criteria: Women with retained placenta, at a gestational age of 28 weeks or more and blood loss less than 750 ml, 30 minutes after delivery of the newborn despite active management of third stage of labour. Trial Entry & Randomisation & Study Medication: After obtaining informed consent, eligible women will be allocated randomly to the treatment groups using numbered envelopes that will be randomized in variable blocks containing identical capsules with either 800 microgram of misoprostol or placebo. The drugs will be given sublingually. The women, maternal care providers and researchers will be blinded to treatment allocation.

Sample size: 117 women, to show a 40% reduction in manual removals of the placenta (p = 0.05, 80% power). The randomization will be misoprostol: placebo = 2:1. PRIMARY STUDY OUTCOME: Expulsion of the placenta without manual removal. Secondary outcome is the number of blood transfusions.

Discussion: This is a protocol for a randomized trial in a low resource setting to assess if medical treatment of women with retained placenta with misoprostol reduces the incidence of manual removal of the placenta.

Clinical trial registration: Current Controlled Trials ISRCTN16104753.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart for trial entry. AMTSL = Active management of third stage of labour. RP = retained placenta. CCT = controlled cord traction. Hb = Haemoglobin. BP = Blood pressure. MRP = Manual removal of placenta. Hb = haemoglobine.

References

    1. Oxorn H. Human Labor & Birth. In: Oxorn H, editor. Human Labor & Birth. 4. London: Prentice-Hall; 1986. pp. 555–565.
    1. Weeks A. The retained placenta. Best Practice & Research Clinical Obstetrics & Gynaecology. 2008;22:1103–1117. doi: 10.1016/j.bpobgyn.2008.07.005. - DOI - PubMed
    1. Ministry of Health, United Republic of Tanzania. Safe motherhood reference manual for district level. 2000.
    1. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol. 2004;115:166–172. - PubMed
    1. Dombrowski MP, Bottoms SF, Saleh AA, Hurd WW, Romero R. Third stage of labor: Analysis of duration and clinical practice. American Journal of Obstetrics and Gynecology. 1995;172:1279–1284. doi: 10.1016/0002-9378(95)91493-5. - DOI - PubMed

Publication types

Associated data

LinkOut - more resources